Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Free Cash Flow (2021 - 2025)

P3 Health Partners (PIII) has disclosed Free Cash Flow for 5 consecutive years, with -$15.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Free Cash Flow rose 26.49% year-over-year to -$15.4 million, compared with a TTM value of -$122.7 million through Sep 2025, down 139.57%, and an annual FY2024 reading of -$110.1 million, down 41.45% over the prior year.
  • Free Cash Flow was -$15.4 million for Q3 2025 at P3 Health Partners, up from -$16.6 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$1.2 million in Q2 2023 and bottomed at -$57.2 million in Q4 2024.
  • Average Free Cash Flow over 5 years is -$22.5 million, with a median of -$21.0 million recorded in 2024.
  • The sharpest move saw Free Cash Flow skyrocketed 97.41% in 2023, then plummeted 762.12% in 2024.
  • Year by year, Free Cash Flow stood at -$11.6 million in 2021, then plummeted by 175.0% to -$31.9 million in 2022, then surged by 96.28% to -$1.2 million in 2023, then plummeted by 4718.01% to -$57.2 million in 2024, then soared by 73.07% to -$15.4 million in 2025.
  • Business Quant data shows Free Cash Flow for PIII at -$15.4 million in Q3 2025, -$16.6 million in Q2 2025, and -$33.5 million in Q1 2025.